Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation
Delapierre, B., Reman, O., Dina, J., Breuil, C., Bellal, M., Johnson-Ansah, H., Gac, A.C., Damaj, G., Chantepie, S.
Published in Current research in translational medicine (01.11.2019)
Published in Current research in translational medicine (01.11.2019)
Get full text
Journal Article